Patents by Inventor John Robblee

John Robblee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods related to biologics
    Patent number: 12360119
    Abstract: The present disclosure relates to the characterization and production of biologics.
    Type: Grant
    Filed: June 8, 2023
    Date of Patent: July 15, 2025
    Assignee: MOMENTA PHARMACEUTICALS, INC.
    Inventor: John Robblee
  • METHODS RELATED TO BIOLOGICS
    Publication number: 20230324406
    Abstract: The present disclosure relates to the characterization and production of biologics.
    Type: Application
    Filed: June 8, 2023
    Publication date: October 12, 2023
    Inventor: John Robblee
  • Methods related to biologics
    Patent number: 11719704
    Abstract: The present disclosure relates to the characterization and production of biologics.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: August 8, 2023
    Assignee: MOMENTA PHARMACEUTICALS, INC.
    Inventor: John Robblee
  • Methods Related to Alemtuzumab
    Publication number: 20200354465
    Abstract: The present invention relates to the characterization and production of alemtuzumab.
    Type: Application
    Filed: April 3, 2020
    Publication date: November 12, 2020
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Methods of manufacturing therapeutic proteins
    Patent number: 10774353
    Abstract: Disclosed herein are methods of manufacturing therapeutic proteins.
    Type: Grant
    Filed: April 27, 2016
    Date of Patent: September 15, 2020
    Assignees: MOMENTA PHARMACEUTICALS, INC., BIOFACTURA, INC.
    Inventors: Rasheed Tijani, Darryl Bacon Sampey, John Robblee, Gan Wei, Chaomei He
  • Analysis of Disulfide Bonds
    Publication number: 20200109432
    Abstract: The present disclosure relates to methods of evaluating, identifying, and/or producing (e.g., manufacturing) pharmaceutical products (e.g., protein therapeutics). In some instances, methods herein allow highly resolved evaluation of the disulfide bond profiles of protein therapeutics.
    Type: Application
    Filed: July 8, 2019
    Publication date: April 9, 2020
    Inventors: Brian Collins, John Robblee, Nathaniel Washburn, Yan Yin, Enrique Arevalo
  • Methods related to CTLA4-Fc fusion proteins
    Patent number: 10450361
    Abstract: The present disclosure provides, in part, methods for evaluating, identifying, and/or producing (e.g., manufacturing) a CTLA4-Fc fusion protein, e.g., abatacept. In some instances, methods herein allow highly resolved evaluation of abatacept useful for, inter alia, manufacturing abatacept, characterizing abatacept, identifying and/or confirming abatacept, monitoring the structure of abatacept, comparing abatacept preparations made over time or made under different conditions, and/or controlling the structure of abatacept.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: October 22, 2019
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: John Robblee, Xiaomei He, Yan Yin, Yin Yin Lin, Brian Collins, Jennifer Murphy, Ganesh Kaundinya
  • Methods related to biologics
    Patent number: 10266590
    Abstract: The present invention relates to the characterization and production of biologics.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: April 23, 2019
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Brian Edward Collins, Joseph Glajch, John Robblee
  • METHODS RELATED TO ADALIMUMAB
    Publication number: 20190077857
    Abstract: The present invention relates to the characterization and production of adalimumab.
    Type: Application
    Filed: May 9, 2018
    Publication date: March 14, 2019
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • METHODS OF EVALUATING AND MAKING BIOLOGICS
    Publication number: 20190079101
    Abstract: Methods of making and evaluating biologic therapeutic products are disclosed.
    Type: Application
    Filed: April 9, 2018
    Publication date: March 14, 2019
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • METHODS RELATED TO BIOLOGICS
    Publication number: 20190025325
    Abstract: The present disclosure relates to the characterization and production of biologics.
    Type: Application
    Filed: December 28, 2016
    Publication date: January 24, 2019
    Inventor: John Robblee
  • Methods related to denosumab
    Patent number: 9695244
    Abstract: The present invention relates to the characterization and production of denosumab.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: July 4, 2017
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • METHODS RELATED TO BIOLOGICS
    Publication number: 20170152319
    Abstract: The present invention relates to the characterization and production of biosimilars.
    Type: Application
    Filed: September 1, 2016
    Publication date: June 1, 2017
    Inventors: Brian Edward Collins, Joseph Glajch, John Robblee
  • METHODS RELATED TO BIOLOGICS
    Publication number: 20170074890
    Abstract: The present invention relates to the characterization and production of biologics.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 16, 2017
    Inventors: Brian Edward Collins, Joseph Glajch, John Robblee
  • METHODS RELATED TO DENOSUMAB
    Publication number: 20150246974
    Abstract: The present invention relates to the characterization and production of denosumab.
    Type: Application
    Filed: May 31, 2013
    Publication date: September 3, 2015
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • METHODS OF EVALUATING AND MAKING BIOLOGICS
    Publication number: 20150204884
    Abstract: Methods of making and evaluating antibody biological therapeutics (biosimilars) for adalimumab, rituximab and panitumumab are disclosed.
    Type: Application
    Filed: May 31, 2013
    Publication date: July 23, 2015
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • METHODS RELATED TO ADALIMUMAB
    Publication number: 20150158943
    Abstract: Production and bioanalytical characterization of determinative parameters of adalimumab is presented.
    Type: Application
    Filed: May 31, 2013
    Publication date: June 11, 2015
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • METHODS RELATED TO PANITUMUMAB
    Publication number: 20150152184
    Abstract: The present invention relates to the characterization and production of panitumumab.
    Type: Application
    Filed: May 31, 2013
    Publication date: June 4, 2015
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • METHODS RELATED TO BEVACIZUMAB
    Publication number: 20150147317
    Abstract: The present invention relates to the characterization and production of bevacizumab.
    Type: Application
    Filed: May 31, 2013
    Publication date: May 28, 2015
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • METHODS RELATED TO RITUXIMAB
    Publication number: 20150141620
    Abstract: The present invention relates to the characterization and production of rituximab.
    Type: Application
    Filed: May 31, 2013
    Publication date: May 21, 2015
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques